Vimarsana
Biggest News Aggregation in the World

Page 40 - Na Sequencing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Na Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Na Sequencing Today - Breaking & Trending Today

Global NGS Market 2021 to 2026: Significant Investments in - Vimarsana News

Global NGS Market 2021 to 2026: Significant Investments in

Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Next Generation Sequencing Market - Forecasts from 2021 to 2026" report has been added to...

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years - Vimarsana News

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications.

The top 10 medtech IPOs of 2021 - Vimarsana News

The top 10 medtech IPOs of 2021

The second year of the COVID-19 pandemic saw a wave of global demand for coronavirus tests that finally reached the public markets. Diagnostics companies raised hundreds of millions of, and in some cases over a billion, dollars by pitching Wall Street on their ability to meet that need.

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV - Vimarsana News

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Researchers characterized the responses of the PBMCs at the individual cell and cell type levels against SARS-CoV-2 and SARS-CoV ex vivo.

New cell model for Alzheimer's disease could be useful in early diagnosis and testing of new therapies - Vimarsana News

New cell model for Alzheimer's disease could be useful in early diagnosis and testing of new therapies

Researchers at the University of Eastern Finland have developed and characterized a new cell model for Alzheimer's disease that has wide utility for research and could prove useful in early diagnosis and testing of new therapies.